Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1990 Sep;101(1):212–216. doi: 10.1111/j.1476-5381.1990.tb12115.x

Evidence for the presynaptic action of 5-hydroxytryptamine and the involvement of purinergic innervation in the rabbit lower urinary tract.

H I Chen 1
PMCID: PMC1917638  PMID: 2178017

Abstract

1. The effects of 5-hydroxytryptamine (5-HT) were studied in vitro on bladder and urethral muscle strips from the rabbit. 5-HT produced dose-dependent contraction in the detrusor and urethra. 2. The 5-HT-induced contraction could be dose-dependently inhibited by the 5-HT3 antagonists MDL 72222, ICS 205-930 and BRL 43694. No effect of ketanserin, methysergide or metitepine was observed on the contractile response to 5-HT. 3. Atropine and alpha, beta-methylene ATP both partially blocked the contractile response to 5-HT. Together they caused more inhibition than either alone. 4. Atropine and alpha, beta-methylene ATP also inhibited the contractile response to electrical field stimulation. The 5-HT3 antagonist MDL 72222 had no effect on the contraction to field stimulation. 5. The atropine- and alpha, beta-methylene ATP-resistant components of 5-HT-induced contraction were not affected by the 5-HT1 antagonists metitepine, the 5-HT2 antagonists ketanserin and methysergide or the 5-HT3 antagonists MDL 72222, ICS 205-930 and BRL 43694. 6. Tetrodotoxin, hexamethonium, phentolamine and prazosin had no effect on the contractile response to 5-HT. 7. These results suggest that in the rabbit lower urinary tract (i) there are 5-HT3 receptors, (ii) the contractile response to 5-HT is mediated by presynaptic stimulation, (iii) there is non-adrenergic, non-cholinergic excitatory neurotransmission.

Full text

PDF
212

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMBACHE N. The use and limitations of atropine for pharmacological studies on autonomic effectors. Pharmacol Rev. 1955 Dec;7(4):467–494. [PubMed] [Google Scholar]
  2. Aas P. Serotonin induced release of acetylcholine from neurons in the bronchial smooth muscle of the rat. Acta Physiol Scand. 1983 Mar;117(3):477–480. doi: 10.1111/j.1748-1716.1983.tb00026.x. [DOI] [PubMed] [Google Scholar]
  3. Ambache N., Zar M. A. Non-cholinergic transmission by post-ganglionic motor neurones in the mammalian bladder. J Physiol. 1970 Oct;210(3):761–783. doi: 10.1113/jphysiol.1970.sp009240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brading A. F., Mostwin J. L. Electrical and mechanical responses of guinea-pig bladder muscle to nerve stimulation. Br J Pharmacol. 1989 Dec;98(4):1083–1090. doi: 10.1111/j.1476-5381.1989.tb12651.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bradley P. B., Engel G., Feniuk W., Fozard J. R., Humphrey P. P., Middlemiss D. N., Mylecharane E. J., Richardson B. P., Saxena P. R. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology. 1986 Jun;25(6):563–576. doi: 10.1016/0028-3908(86)90207-8. [DOI] [PubMed] [Google Scholar]
  6. Burnstock G., Dumsday B., Smythe A. Atropine resistant excitation of the urinary bladder: the possibility of transmission via nerves releasing a purine nucleotide. Br J Pharmacol. 1972 Mar;44(3):451–461. doi: 10.1111/j.1476-5381.1972.tb07283.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Costa M., Furness J. B. The sites of action of 5-hydroxytryptamine in nerve-muscle preparations from the guinea-pig small intestine and colon. Br J Pharmacol. 1979 Feb;65(2):237–248. doi: 10.1111/j.1476-5381.1979.tb07824.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Downie J. W., Dean D. M. The contribution of cholinergic postganglionic neurotransmission to contractions of rabbit detrusor. J Pharmacol Exp Ther. 1977 Nov;203(2):417–425. [PubMed] [Google Scholar]
  9. Drakontides A. B., Gershon M. D. 5-hydroxytryptamine receptors in the mouse duodenum. Br J Pharmacol Chemother. 1968 Jul;33(3):480–492. doi: 10.1111/j.1476-5381.1968.tb00496.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fozard J. R. Neuronal 5-HT receptors in the periphery. Neuropharmacology. 1984 Dec;23(12B):1473–1486. doi: 10.1016/0028-3908(84)90091-1. [DOI] [PubMed] [Google Scholar]
  11. Fujii K. Evidence for adenosine triphosphate as an excitatory transmitter in guinea-pig, rabbit and pig urinary bladder. J Physiol. 1988 Oct;404:39–52. doi: 10.1113/jphysiol.1988.sp017277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. GADDUM J. H., PICARELLI Z. P. Two kinds of tryptamine receptor. Br J Pharmacol Chemother. 1957 Sep;12(3):323–328. doi: 10.1111/j.1476-5381.1957.tb00142.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. GYERMEK L. Action of 5-hydroxytryptamine on the urinary bladder of the dog. Arch Int Pharmacodyn Ther. 1962 May 1;137:137–144. [PubMed] [Google Scholar]
  14. GYERMEK L. Cholinergic stimulation and blockade on urinary bladder. Am J Physiol. 1961 Aug;201:325–328. doi: 10.1152/ajplegacy.1961.201.2.325. [DOI] [PubMed] [Google Scholar]
  15. Higashi H., Nishi S. 5-Hydroxytryptamine receptors of visceral primary afferent neurones on rabbit nodose ganglia. J Physiol. 1982 Feb;323:543–567. doi: 10.1113/jphysiol.1982.sp014091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hirai K., Koketsu K. Presynaptic regulation of the release of acetylcholine by 5-hydroxytryptamine. Br J Pharmacol. 1980 Nov;70(3):499–500. doi: 10.1111/j.1476-5381.1980.tb08729.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Holt S. E., Cooper M., Wyllie J. H. On the nature of the receptor mediating the action of 5-hydroxytryptamine in potentiating responses of the mouse urinary bladder strip to electrical stimulation. Naunyn Schmiedebergs Arch Pharmacol. 1986 Dec;334(4):333–340. doi: 10.1007/BF00569366. [DOI] [PubMed] [Google Scholar]
  18. Jin J. G., Neya T., Nakayama S. Myenteric 5-HT-containing neurones activate the descending cholinergic excitatory pathway to the circular muscle of guinea-pig ileum. Br J Pharmacol. 1989 Nov;98(3):982–988. doi: 10.1111/j.1476-5381.1989.tb14629.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. KURU M. NERVOUS CONTROL OF MICTURITION. Physiol Rev. 1965 Jul;45:425–494. doi: 10.1152/physrev.1965.45.3.425. [DOI] [PubMed] [Google Scholar]
  20. Kasakov L., Burnstock G. The use of the slowly degradable analog, alpha, beta-methylene ATP, to produce desensitisation of the P2-purinoceptor: effect on non-adrenergic, non-cholinergic responses of the guinea-pig urinary bladder. Eur J Pharmacol. 1982 Dec 24;86(2):291–294. doi: 10.1016/0014-2999(82)90330-2. [DOI] [PubMed] [Google Scholar]
  21. Klarskov P., Hørby-Petersen J. Influence of serotonin on lower urinary tract smooth muscle in vitro. Br J Urol. 1986 Oct;58(5):507–513. doi: 10.1111/j.1464-410x.1986.tb05456.x. [DOI] [PubMed] [Google Scholar]
  22. Langley J. N., Anderson H. K. The Innervation of the Pelvic and adjoining Viscera: Part II. The Bladder. Part III. The External Generative Organs. Part IV. The Internal Generative Organs. Part V. Position of the Nerve Cells on the Course of the Efferent Nerve Fibres. J Physiol. 1895 Dec 30;19(1-2):71–139. doi: 10.1113/jphysiol.1895.sp000587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. MacKay D. How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated? J Pharm Pharmacol. 1978 May;30(5):312–313. doi: 10.1111/j.2042-7158.1978.tb13237.x. [DOI] [PubMed] [Google Scholar]
  24. Nelson D. R., Thomas D. R. [3H]-BRL 43694 (Granisetron), a specific ligand for 5-HT3 binding sites in rat brain cortical membranes. Biochem Pharmacol. 1989 May 15;38(10):1693–1695. doi: 10.1016/0006-2952(89)90319-5. [DOI] [PubMed] [Google Scholar]
  25. Richardson B. P., Engel G., Donatsch P., Stadler P. A. Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature. 1985 Jul 11;316(6024):126–131. doi: 10.1038/316126a0. [DOI] [PubMed] [Google Scholar]
  26. Sanger G. J. Increased gut cholinergic activity and antagonism of 5-hydroxytryptamine M-receptors by BRL 24924: potential clinical importance of BRL 24924. Br J Pharmacol. 1987 May;91(1):77–87. doi: 10.1111/j.1476-5381.1987.tb08985.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Saum W. R., De Groat W. C. The actions of 5-hydroxytryptamine on the urinary bladder and on vesical autonomic ganglia in the cat. J Pharmacol Exp Ther. 1973 Apr;185(1):70–83. [PubMed] [Google Scholar]
  28. Saxena P. R., Heiligers J., Mylecharane E. J., Tio R. Excitatory 5-hydroxytryptamine receptors in the cat urinary bladder are of the M- and 5-HT2-type. J Auton Pharmacol. 1985 Jun;5(2):101–107. doi: 10.1111/j.1474-8673.1985.tb00110.x. [DOI] [PubMed] [Google Scholar]
  29. Shuster M. J., Camardo J. S., Siegelbaum S. A., Kandel E. R. Cyclic AMP-dependent protein kinase closes the serotonin-sensitive K+ channels of Aplysia sensory neurones in cell-free membrane patches. 1985 Jan 31-Feb 6Nature. 313(6001):392–395. doi: 10.1038/313392a0. [DOI] [PubMed] [Google Scholar]
  30. Taira N. The autonomic pharmacology of the bladder. Annu Rev Pharmacol. 1972;12:197–208. doi: 10.1146/annurev.pa.12.040172.001213. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES